Sign In
Buy SCPS
$0.0004
+0 (+0%)
At Close: Jun 22, 2026
Duet releases video depicting mechanism of action for its proprietary CpG-STAT3 inhibitors to coincide with Duet presentations at OTS Meeting Duet releases video depicting mechanism of action for its
Scopus BioPharma to Adjourn 2021 Annual Meeting of Stockholders
06:00am, Tuesday, 28'th Sep 2021
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with s
Scopus BioPharma's Subsidiary — Duet Therapeutics — to Present at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
08:30am, Wednesday, 22'nd Sep 2021
Alan Horsager, Ph.D., President and Chief Executive Officer of Duet Therapeutics, will present on CpG-STAT3 RNA Silencing and Antisense inhibitors
New patent covers compound and composition and methods of use for CpG-STAT3 Antisense inhibitor (CpG-STAT3ASO)
JERUSALEM, Sept. 20, 2021 /PRNewswire/ -- Dr. Morris C.
Scopus BioPharma's Subsidiary — Duet Therapeutics — Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific Advisor
09:15am, Tuesday, 07'th Sep 2021
Dr. Kortylewski is the Leading Authority on Bi-Functional Oligonucleotide Cancer Therapeutics and a Professor in the Department of Immuno-Oncology at the Beckman Research Institute at City of Hope Nat
Scopus BioPharma's Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium Meeting
09:25am, Friday, 03'rd Sep 2021
Alan Horsager, Ph.D., President and Chief Executive Officer of Duet, to Present on Clinical Development of CpG-STAT3 Inhibitors Alan Horsager, Ph.D., President and Chief Executive Officer of Duet, to
Scopus BioPharma Launches Duet Therapeutics
09:15am, Thursday, 02'nd Sep 2021
Duet Therapeutics Integrates Immunotherapy Assets of Scopus and Olimmune, Acquired by Scopus in June 2021
5 Best Penny Stocks To Buy Right Now According To Insiders
10:53am, Wednesday, 25'th Aug 2021
5 Penny Stocks Insiders Are Buying Right Now The post 5 Best Penny Stocks To Buy Right Now According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Scopus BioPharma Announces New Management Appointment Following Acquisition of Leading Immunotherapy Company
08:30am, Monday, 12'th Jul 2021
NEW YORK, July 12, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with si
Scopus BioPharma Announces New Date for 2021 Annual Meeting of Stockholders
08:30pm, Monday, 31'st May 2021
NEW YORK, May 31, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced that the board of directors has rescheduled the company's 2021 Annual Meeting of Stockholders (“
Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders
07:30pm, Wednesday, 26'th May 2021
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced it will be rescheduling the company's 2021 Annual Meeting of Shareholders (the “2021 Annual Meet
SCPS Stock Price: 71.98% Increase Explanation
08:40am, Tuesday, 25'th May 2021
The stock price of Scopus BioPharma Inc. (NASDAQ: SCPS) increased by 71.98% yesterday. This is why it happened.
Why Scopus BioPharma's Stock Is Surging Today
02:45pm, Monday, 24'th May 2021
Scopus BioPharma (NASDAQ:SCPS) shares are trading higher after the company announced the FDA has approved its IND application for CpG-STAT3siRNA, the company's distinctive immuno-oncology RNA therap
Why Scopus, NGM Biopharma and Taiwan Liposome Are Moving Today
12:53pm, Monday, 24'th May 2021
Scopus BioPharma Inc. (NASDAQ: SCPS), NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) and Taiwan Liposome Company, Ltd. (NASDAQ: TLC) are among the biggest biopharma movers Monday.
